BridgeBio Oncology Therapeutics, Inc. (BBOT) Insider Trading -- Recent Executive & Director Transactions
11 insiders reported 33 Form 4 transactions for BridgeBio Oncology Therapeutics, Inc. (BBOT) over the past 18 months (most recent 2026-10-05). Recent activity: Cobo Marc (Principal Accounting Officer) Sell 126 shares, Ben Yong (Chief Med & Dev Officer) Sell 1,047 shares, Beltran Pedro (President and CEO) Sell 1,047 shares, Elmelech Idan (COO & Principal Financial Ofcr) Sell 343 shares, Cobo Marc (Principal Accounting Officer) Buy 9,038 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Cobo Marc | Principal Accounting Officer | Sell | 126 | $496 |
| 2026-10-05 | Ben Yong | Chief Med & Dev Officer | Sell | 1,047 | $4,125 |
| 2026-10-05 | Beltran Pedro | President and CEO | Sell | 1,047 | $4,125 |
| 2026-10-05 | Elmelech Idan | COO & Principal Financial Ofcr | Sell | 343 | $1,351 |
| 2026-09-14 | Cobo Marc | Principal Accounting Officer | Buy | 9,038 | $0 |
| 2026-09-14 | Cobo Marc | Principal Accounting Officer | Sell | 203 | $1,121 |
| 2026-07-06 | Chen Bihua | Director | Buy | 1.7M | $0 |
| 2026-07-06 | Cobo Marc | Principal Accounting Officer | Sell | 125 | $975 |
| 2026-07-06 | Ben Yong | Chief Med & Dev Officer | Sell | 1,047 | $8,167 |
| 2026-07-06 | Beltran Pedro | President and CEO | Sell | 1,047 | $8,167 |
| 2026-07-06 | Elmelech Idan | COO & Principal Financial Ofcr | Sell | 343 | $2,675 |
| 2026-07-06 | Chen Bihua | Director | Buy | 2.7M | $0 |
| 2026-07-06 | Chen Bihua | Director | Sell | 4.5M | $0 |
| 2026-07-06 | Chen Bihua | Director | Buy | 130,865 | $0 |
| 2026-05-05 | Ben Yong | Chief Med & Dev Officer | Sell | 1,047 | $9,454 |
| 2026-05-05 | Beltran Pedro | President and CEO | Sell | 1,047 | $9,454 |
| 2026-05-05 | Mehra Uneek | Insider | Sell | 524 | $4,732 |
| 2026-03-12 | Beltran Pedro | Chief Scientific Officer | Buy | 46,670 | $0 |
| 2026-03-12 | Mehra Uneek | Chief Financial Officer | Buy | 23,330 | $0 |
| 2026-03-12 | Ben Yong | Chief Med & Dev Officer | Buy | 46,670 | $0 |
| 2025-10-16 | BridgeBio Pharma, Inc. | 10% Owner | Buy | 784,720 | $0 |
| 2025-10-16 | BridgeBio Pharma LLC | 10% Owner | Buy | 784,720 | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 4.2M | $0 |
| 2025-08-13 | Chen Bihua | Director | Sell | 152,940 | $0 |
| 2025-08-13 | Chen Bihua | Director | Buy | 760,496 | $8.2M |
Source: SEC Form 4 filings · as of 2026-10-05